insights_auto
Why is ARWR down 2.87%?
Dive Deeperchevron_right
ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$62.35
arrow_downward
-2.87%(-1.84) 1D
$62.35
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$64.76
High
$64.76
Low
$62.22
Mkt. cap
8.81B
Avg. vol.
1.96M
Volume
0.00
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
Open
$64.76
High
$64.76
Low
$62.22
Mkt. cap
8.81B
Avg. vol.
1.96M
Volume
0.00
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
AOL.com
·
41 minutes ago
Everli, a Leading Italian E-Grocery Marketplace, Advances Toward Nasdaq Listing as SEC Declares Registration Statement Effective
Simply Wall Street
·
12 minutes ago
Pool (POOL) Appoints Jean Marc Germain To Its Board
StockStory
·
13 minutes ago
1 S&P 500 Stock on Our Watchlist and 2 We Avoid
Yahoo Finance
·
37 minutes ago
US Stock Market Today: S&P 500 Futures Dip As Cooling Wages Temper Growth Hopes
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com